This timeline allows your body to clear the medication and metabolize any remaining compound, reducing theoretical fetal exposure risk
The immunopathology of sepsis and potential therapeutic targets
Browse our full research peptides catalog for complementary compounds, or scroll on for the complete technical brief on FOXO4-DRI
1 1 2 Weight loss outcomes by engagement quartile *Based on a January 2026 analysis of 14,210 Noom GLP-1 Rx program members who joined between December 2024 and February 2025 and logged weight during a measurement week (4, 8, 16, 40 weeks) Total months persisted by engagement quartile *Based on a January 2026 analysis of 30,239 Noom GLP-1 Rx program members who joined between December 2024 and February 2025 Frequently Asked Questions Weight Loss and Engagement: January 2026 analysis of 14,203 Noom GLP-1 Rx Program members who started a GLP-1Rx plan between December 2024 and February 2025 and logged weight during a measurement week (4, 8, 16, 40 weeks)
doi: 10.1038/nrendo.2014.171 31
Every one of the drugs was subsequently withdrawn, mainly because of psychiatric and/or cardiovascular adverse reactions
